Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kimmel

Showing results (161-170 of 550) with videos related to

Pageof 55
Sort By:
Journal of the American Society of Nephrology : JASN|May 30, 2008
Association of incident gout and mortality in dialysis patientsScott D Cohen, Paul L Kimmel, Robert Neff, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Screening, diagnosis, and treatment of depression in patients with end-stage renal diseaseScott D Cohen, Lorenzo Norris, Kimberly Acquaviva, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantationM Thamer, J K Chan, N F Ray, et al.
Seminars in Dialysis|March 18, 2005
Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patientsArchana K Shayamsunder, Samir S Patel, Vivek Jain, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2004
The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndromeBipinchandra Mistry, Paul L Kimmel, Paul C Hetzel, et al.
Teratology|January 1, 1996
Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetusesJ E Polifka, J C Rutledge, G L Kimmel, et al.
Life Sciences|June 13, 2003
CART peptides are modulators of mesolimbic dopamine and psychostimulantsJ N Jaworski, A Vicentic, R G Hunter, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicityPaul L Kimmel, Seth L Emont, John M Newmann, et al.
Kidney International|March 25, 2011
The severity of acute kidney injury predicts progression to chronic kidney diseaseLakhmir S Chawla, Richard L Amdur, Susan Amodeo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Pain, sleep disturbance, and quality of life in patients with chronic kidney diseaseScott D Cohen, Samir S Patel, Prashant Khetpal, et al.
Pageof 55

Showing results (161-170 of 550) with videos related to

Sort By:
Pageof 55
Journal of the American Society of Nephrology : JASN|May 30, 2008
Association of incident gout and mortality in dialysis patientsScott D Cohen, Paul L Kimmel, Robert Neff, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Screening, diagnosis, and treatment of depression in patients with end-stage renal diseaseScott D Cohen, Lorenzo Norris, Kimberly Acquaviva, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantationM Thamer, J K Chan, N F Ray, et al.
Seminars in Dialysis|March 18, 2005
Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patientsArchana K Shayamsunder, Samir S Patel, Vivek Jain, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2004
The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndromeBipinchandra Mistry, Paul L Kimmel, Paul C Hetzel, et al.
Teratology|January 1, 1996
Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetusesJ E Polifka, J C Rutledge, G L Kimmel, et al.
Life Sciences|June 13, 2003
CART peptides are modulators of mesolimbic dopamine and psychostimulantsJ N Jaworski, A Vicentic, R G Hunter, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicityPaul L Kimmel, Seth L Emont, John M Newmann, et al.
Kidney International|March 25, 2011
The severity of acute kidney injury predicts progression to chronic kidney diseaseLakhmir S Chawla, Richard L Amdur, Susan Amodeo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Pain, sleep disturbance, and quality of life in patients with chronic kidney diseaseScott D Cohen, Samir S Patel, Prashant Khetpal, et al.
Pageof 55